Read the latest positive news, breakthroughs, and inspiring stories about merck, curated daily by BrightWire.
A breakthrough personalized cancer vaccine from Merck and Moderna could soon reach patients faster as manufacturing improves. The treatment has shown promising results in melanoma trials and is being tested for other cancers.
A personalized mRNA cancer vaccine from Merck and Moderna has succeeded in Phase 3 trials, marking a major breakthrough in immunotherapy. The treatment, called intismeran autogene, tailors cancer-fighting instructions to each patient's unique tumor.
Merck just agreed to let seven companies make free generic versions of its experimental HIV prevention pill for low and middle-income countries. The pharmaceutical giant isn't waiting for approval—it's planning ahead so millions can access the once-a-month pill as soon as it's ready.
Millions with high cholesterol just got a simpler treatment option. The FDA approved Merck's new pill that could replace regular injections for heart disease prevention.
A breakthrough cholesterol pill from Merck just proved it works as well as injections, making life-saving heart disease treatment easier than ever. With heart disease still America's number one killer for a century, this daily pill could help 70% of patients who aren't reaching their cholesterol goals.